Study details
Enrolling now
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System
Epitel, Inc.
NCT IDNCT06027749ClinicalTrials.gov data as of Apr 2026
Target enrollment
65
Study length
about 1.6 years
Ages
18–70
Locations
2 sites in FL, SC
What this study is about
This trial is testing a device called REMI™ to record brain activity (EEG) for longer periods than usual in people with epilepsy. The goal is to see if this extended monitoring helps doctors better understand seizures.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Epitel's™ Remote EEG Monitoring System's (REMI™)
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Neurology